May 31, 2013 · Comments Off
Researchers at University of Colorado Cancer Center are discovering how androgens drive diseases such as breast and bladder cancers.
AACR News: Studies show increasing evidence that androgen drives breast cancer
April 10, 2013 · Comments Off
Estrogen and progesterone receptors, and the gene HER2 – these are the big three markers and/or targets in breast cancer. Evidence presented at the AACR Annual Meeting 2013 adds a fourth: androgen receptors.
Clinical trial hits new target in war on breast cancer
December 3, 2012 · Comments Off
KEY POINTS: In addition to estrogen, progesterone and HER2, androgen drives breast cancer The drug...
Annual retreat shows the CU Cancer Center is greater than the sum of its parts
October 31, 2012 · Comments Off
At the annual CU Cancer Center retreat on October 30, Deputy Director Andrew Thorburn, PhD,...
In this every-second-Thursday “Decoding Cancer” series in Target Cancer, and in honor of National Breast...
Safeway gift brings total breast cancer research support at CU Cancer Center above $1 million
April 22, 2011 · Comments Off
A $350,000 gift from Safeway, Inc. will fund breast cancer research at the University of...
Buchmeier: CIC sets sky-high goals to benefit our patients
November 9, 2010 · Comments Off
When I came to manage the UCCC Clinical Investigations Core in the summer of 2004,...
New trial for women with triple-negative breast cancer opens at UCCC
November 3, 2010 · Comments Off
PARP inhibitor could increase prognosis for women with residual cancer in tumor samples For clinical...
Safeway donates $176,000 to UCCC breast cancer research
April 21, 2010 · Comments Off
Check-stand “rounding up” program results in $800,000 total gift to program since 2007 Breast cancer...
NTRK1: a new oncogene and target in lung cancer
April 21, 2010
ALK alk drug lung cancer ALL amc cancer fund American Association for Cancer Research andrew thorburn anthony elias antonio jimeno biomarkers bladder cancer breast cancer cancer grants cancer research colorado Cancer Survivorship cell signaling clinical trial colorado cancer benefit colorectal cancer crizotinib CU Cancer Center Dan Theodorescu fred hirsch funding opportunity grant head-and-neck cancer james degregori jennifer richer leukemia lung cancer lung cancer research melanoma metastasis Pancreatic cancer paul bunn prostate cancer publications rajesh agarwal ross camidge screening skin cancer tim byers university of colorado cancer center university of colorado hospital university of colorado school of medicine wells messersmith
I posted 45 photos on Facebook in the album "Dress In Blue 2014" http://t.co/p7qOfCsqKJ
Thank you to everyone who attended last week's Dress in Blue Eve event at Breckenridge Brewery and for all those... http://t.co/tcoNIu75up
Today is the day! Enjoy some blueberry pancakes and dress in all blue for Dress in Blue day to increase... http://t.co/LnYh9iT1lW
One last reminder. Wear blue tomorrow for Dress in Blue Day! http://t.co/dNKEDueKNv
In Health Care, Choice Is Overrated. We're glad our patient got the second opinion needed. Hope others can too. http://t.co/3T9CrAj8E2